1
Clinical Trials associated with Yttrium-90 Radiolabeled Anti-TacTreatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac
The study purpose is to evaluate the clinical response to multidose administration of anti-Tac monoclonal antibody conjugated with 10 mCi 90Y in patients with Tac-expressing adult T-cell leukemia (ATL).
100 Clinical Results associated with Yttrium-90 Radiolabeled Anti-Tac
100 Translational Medicine associated with Yttrium-90 Radiolabeled Anti-Tac
100 Patents (Medical) associated with Yttrium-90 Radiolabeled Anti-Tac
100 Deals associated with Yttrium-90 Radiolabeled Anti-Tac